Skip to Content
Merck
All Photos(1)

Key Documents

G004245

LC/MS Analysis of Clenbuterol Enantiomers in Plasma on Astec® CHIROBIOTIC® T after SPE using HybridSPE®-Phospholipid

application for HPLC

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

technique(s)

HPLC: suitable

test parameters

column: CHIROBIOTIC T, 10 cm x 2.1 mm I.D., 5 μm particles (12018AST)
mobile phase: 10 mM ammonium formate in methanol
flow rate: 0.3 mL/min
column temp.: 30 °C
detector: ESI(+)
sample: clenbuterol, 10 ng/mL in rat plasma (phospholipids removed by extraction with HybridSPE-Phospholipid)

suitability

application for HPLC

application(s)

clinical
forensics and toxicology
pharmaceutical (small molecule)

Legal Information

Astec is a registered trademark of Merck KGaA, Darmstadt, Germany
CHIROBIOTIC is a registered trademark of Sigma-Aldrich Co. LLC
HybridSPE is a registered trademark of Merck KGaA, Darmstadt, Germany

Analyte

Description
    Clenbuterol hydrochloride

Application

Product No.
Description
Pricing

SPE tube or plate

Product No.
Description
Pricing

analytical column

Product No.
Description
Pricing

standard

Product No.
Description
Pricing

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service